ZOLL Cardiac Management Solutions offers a unique portfolio of novel technologies designed to deliver better insights and better outcomes in cardiac patient care. Solutions include the LifeVest wearable cardioverter defibrillator (WCD), Heart Failure Management System (HFMS), and WatchPAT® ONE Home Sleep Apnea Test. On any given day, clinicians utilize these ZOLL products for tens of thousands of patients around the world.

In 2006, the Cardiac Management Solutions business became a part of ZOLL Medical Corporation, which was acquired by Asahi Kasei in 2012. ZOLL develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and cardiac monitoring, circulation enhancement and CPR feedback, supersaturated oxygen therapy, data management, ventilation, therapeutic temperature management, and sleep apnea diagnosis and treatment, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, as well as lay rescuers, improve patient outcomes in critical cardiopulmonary conditions. Learn more about ZOLL at zoll.com